SCHEMBL13064965

SCHEMBL13064965

O=C(O)c1ccc(O)c(NC(=O)c2cc(O)c(O)c(O)c2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 4/20 0.62
▸ TOP2A P11388 3/20 0.62
▸ TOP2B Q02880 3/20 0.62
▸ KDM5A P29375 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.53
▸ CA12 O43570 2/20 0.53
▸ CA1 P00915 2/20 0.53
▸ CA2 P00918 2/20 0.53
▸ MAPT P10636 2/20 0.53
▸ CA4 P22748 2/20 0.53
▸ CA6 P23280 2/20 0.53
▸ CA7 P43166 2/20 0.53
▸ CA9 Q16790 2/20 0.53
▸ CA14 Q9ULX7 2/20 0.53
▸ POLB P06746 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ PTGS2 P35354 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ SNCA P37840 4/20 0.53
▸ SELL P14151 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13064964 0.88 TOP1 (0.64) TOP1TOP2ATOP2BKDM5AKDM4E
SCHEMBL28477473 0.88 MEN1 (0.60) TOP1KDM5AKDM4ECA12CA1
SCHEMBL28478726 0.86 MEN1 (0.58) TOP1KDM5AKDM4ECA12CA1
SCHEMBL12704788 0.82 NPC1 (0.77) KDM5AMAPTGAAALDH1A1SMN1; SMN2
SCHEMBL29692929 0.81 KDM5A (0.59) TOP1TOP2ATOP2BKDM5AKDM4E
SCHEMBL18027729 0.80 KCNMA1 (0.71) TOP1TOP2ATOP2BMAPTGAA
SCHEMBL18993374 0.80 TOP1 (0.62) TOP1TOP2ATOP2BKDM4EMAPT
SCHEMBL13064992 0.79 TOP1 (0.82) TOP1TOP2ATOP2BKDM4ECA12
SCHEMBL12704786 0.78 GAA (0.52) TOP1KDM5AKDM4ECA12CA1
SCHEMBL12707445 0.78 KDM5A (0.53) KDM5APOLBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 — — US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 — — US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 TOP1 4169/4885TOP2A 4437/4885TOP2B 4174/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 TOP1 4169/4885TOP2A 4437/4885TOP2B 4174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback